Erbe USA Inc recalls ERBECRYO 2 Cryosurgical Unit
The stated reason: A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the re
Erbe USA Inc began a medical device recall on June 26, 2026 whose reported distribution included Ohio. FDA
What the record shows
FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 1126 units. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: June 26, 2026 FDA
- Recall number: Z-2938-2026 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Erbe USA Inc FDA
- Product: ERBECRYO 2 Cryosurgical Unit Model/Catalog Number: 10402-000 FDA
- Reason for recall: A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he… FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
The source filing
| Recall number | Z-2938-2026 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Erbe USA Inc |
| Product | ERBECRYO 2 Cryosurgical Unit Model/Catalog Number: 10402-000 |
| Reason for recall | A strong pull on the high-pressure transfer hose of cryosurgical unit may lead to pneumatic short circuit between he gas inlet and the connector resulting in CO2 leaking into the return path, leading to excessive pressure causing the cryoprobe to rupture. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | medical device |
| Quantity | 1126 units |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20260626 |
| Reported | 20260819 |
| Distribution | US Nationwide distribution including in the states and territories of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexi |
| Firm location | Marietta, GA, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.